Early Access — free while we kick the tires
EdgarHawk

Xu Jiandong

Chief Financial Officer

Officer

Latest: CFO buying · October 2025

1 filing analyzed · 1 company · Latest 2026-04-29

Companies

Company Buys Sells Direction
Estrella Immunopharma, Inc. ESLA 3 0 Net buying

Activity

April 2026
medium
Buy
2,100 shares
$2,594
Significance 4/10

CFO Xu Jiandong bought 2,100 shares (3 purchases, $1.04–$1.33 range) amid -$4.8M net loss; stock up 42.7% in 30 days from $1.04 base.

Xu Jiandong, Chief Financial Officer, executed three separate purchases totaling 2,100 shares for $2,594.00 across September and October 2025, at prices ranging from $1.04 to $1.33 with a blended average of $1.24. The timing of these purchases coincides with significant upward price momentum: the stock has climbed 42.7% over the prior 30 days and 36.1% over 90 days, suggesting the purchases began near recent lows relative to recent trading. However, context is material: the company reported a full-year net loss of $-4,801,149.00 and remains unprofitable. The CFO's modest accumulation—a 0.8% increase in his 265.5K-share post-transaction holdings—occurs against a stock now trading at $1.47, down 51.8% from its 52-week high of $3.05. This filing documents insider buying activity during a recovery phase in an unprofitable company.

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access